iotaMotion Announces Formation Of Scientific Advisory Board For Robotic-Assisted Cochlear Technologies

News provided by

Dec 14, 2017, 08:13 ET

IOWA CITY, Iowa, Dec. 14, 2017 /PRNewswire/ -- iotaMotion, Inc., a medical device company focused on developing advanced robotic systems for cochlear implant surgery, announced today the formation of its Scientific Advisory Board (SAB) with two key appointments: Craig A. Buchman, M.D., and J. Thomas Roland Jr., M.D. two world-renowned cochlear implant surgeons, who join Dr. Bruce Gantz (Chair and Head of the Department of Otolaryngology – Head and Neck Surgery at the University of Iowa) who serves as an esteemed advisor to the company.

The SAB will work closely with the iotaMotion management team as it advances its product pipeline. The company is developing technology that will enable surgeons to achieve more precise, individualized solutions for patients experiencing various types of hearing loss. The company's first product, iotaSOFT™, is a robotic-assisted insertion device that allows surgeons to advance cochlear implant electrodes with the precision of robotics. Controlled insertion will lead to less surgical variability in outcomes and results, while helping to protect existing structures from the damage of manual insertion.

"We are thrilled to have attracted the world's leading experts in cochlear implants as we develop our suite of robotic-assisted systems that have the potential to significantly advance the state of technology for cochlear implant surgery," commented Chris Kaufmann, M.D., co-founder of iotaMotion. "Importantly, the formation of our SAB serves as an endorsement for scientific and clinical enthusiasm for the technologies under development. We look forward to working closely with Dr. Buchman and Dr. Roland."

Dr. Buchman is the Lindburg Professor and Head of Otolaryngology – Head and Neck Surgery at the Washington School of Medicine in St. Louis. Dr. Buchman is a renowned leader in cochlear implants, specifically electrocochleography and its role as an indicator of insertion trauma. He is one of the most active cochlear implant surgeons in the country and his research interests are broad in the field of hearing loss and rehabilitation. Dr. Buchman received his Bachelor's degree in Microbiology from the University of Georgia, and his MD from the University of Florida before his residency in Otolaryngology at the University of Pittsburgh School of Medicine and a fellowship in Otology / Neurotology / Skull Base Surgery at House Ear Institute and Clinic. For more information on Dr. Buchman, please visit: http://oto.wustl.edu/About-Us/Faculty-Physicians/Craig-Buchman.

Dr. John Thomas Roland, Jr., M.D., serves as Chair of the Department of Otolaryngology – Head and Neck Surgery at NYU Langone Medical Center. Dr. Roland is a pioneer in investigating cochlear implant insertion forces and has lead work in early experimental robotic systems. He has significantly advanced the state-of-the-art for ENT patient care through a strong focus on translational and scientific research. Dr. Roland received his Bachelor's degree from the University of Pennsylvania, and his MD from Temple University School of Medicine before his residency and fellowship at NYU Medical Center. For more information on Dr. Roland, please visit: https://nyulangone.org/doctors/1962445411/j-thomas-roland-jr.

IOTAMOTION, INC.

A privately-held Iowa based company, iotaMotion is developing robotic technologies with the goal of focused, individualized, hearing loss treatment. The company's solutions aim to standardize cochlear implant insertion, and to provide unprecedented control in the surgical and post-surgical care settings with the goal of expanding access to cochlear interventions for both surgeons and patients. For more information, visit www.iotamotion.com or contact Chris Kaufmann at [email protected].

SOURCE iotaMotion, Inc.